Verve Therapeutics Inc.
World Rank (Jan-05-2024)
8,130
Market Cap (Jan-05-2024)
1.095 Billion USD
World Rank (Jul-30-2023)
7,713
Market Cap (Jul-30-2023)
1.232 Billion USD
World Rank (Dec-25-2022)
7,827
Market Cap (Dec-25-2022)
1.122 Billion USD
World Rank (Jan-07-2022)
7,318
Market Cap (Jan-07-2022)
1.54 Billion USD
Annual Revenue in USD
2 Million USD
Annual Net Income in USD
-157 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Company Profile
Verve Therapeutics is the preeminent company developing gene editing medicines to treat patients with cardiovascular disease. The headquarters is in USA.
Company Website